
Rei Tsang Shiao
Examiner (ID: 13461)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11827598
[patent_doc_number] => 09724327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Methods of preventing progression to type 2 diabetes mellitus'
[patent_app_type] => utility
[patent_app_number] => 14/509297
[patent_app_country] => US
[patent_app_date] => 2014-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11620
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14509297
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/509297 | Methods of preventing progression to type 2 diabetes mellitus | Oct 7, 2014 | Issued |
Array
(
[id] => 11463762
[patent_doc_number] => 09580379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Xanthine oxidase inhibitors and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/508960
[patent_app_country] => US
[patent_app_date] => 2014-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 16233
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14508960
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/508960 | Xanthine oxidase inhibitors and methods of use | Oct 6, 2014 | Issued |
Array
(
[id] => 10089137
[patent_doc_number] => 09125945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/507693
[patent_app_country] => US
[patent_app_date] => 2014-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 31705
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14507693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/507693 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use | Oct 5, 2014 | Issued |
Array
(
[id] => 9813111
[patent_doc_number] => 20150025056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES'
[patent_app_type] => utility
[patent_app_number] => 14/506333
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86950
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506333
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506333 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | Oct 2, 2014 | Issued |
Array
(
[id] => 10209316
[patent_doc_number] => 20150094307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/503919
[patent_app_country] => US
[patent_app_date] => 2014-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25228
[patent_no_of_claims] => 132
[patent_no_of_ind_claims] => 106
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14503919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/503919 | Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof | Sep 30, 2014 | Issued |
Array
(
[id] => 10481963
[patent_doc_number] => 20150366980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'Mineral Amino-Acid Complexes of Fatty Acids'
[patent_app_type] => utility
[patent_app_number] => 14/504247
[patent_app_country] => US
[patent_app_date] => 2014-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12352
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14504247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/504247 | Mineral amino-acid complexes of fatty acids | Sep 30, 2014 | Issued |
Array
(
[id] => 9799526
[patent_doc_number] => 20150011470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/491016
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30019
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491016
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/491016 | N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors | Sep 18, 2014 | Issued |
Array
(
[id] => 9799698
[patent_doc_number] => 20150011642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'GREASE-LIKE GEL FOR REPELLING INSECTS AND PREVENTING UNDESIRABLE BEHAVIOR IN HOOFED ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 14/491837
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10784
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491837
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/491837 | Grease-like gel for repelling insects and preventing undesirable behavior in hoofed animals | Sep 18, 2014 | Issued |
Array
(
[id] => 10175913
[patent_doc_number] => 09206103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 14/486679
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 11741
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486679 | Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases | Sep 14, 2014 | Issued |
Array
(
[id] => 11342326
[patent_doc_number] => 09526710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Treatment and diagnosis of melanoma'
[patent_app_type] => utility
[patent_app_number] => 14/486477
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 61
[patent_no_of_words] => 66537
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486477
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486477 | Treatment and diagnosis of melanoma | Sep 14, 2014 | Issued |
Array
(
[id] => 12486555
[patent_doc_number] => 09993456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Preparation and use of a composition for prevention and mitigation of the effects of radiation
[patent_app_type] => utility
[patent_app_number] => 15/021376
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5869
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021376 | Preparation and use of a composition for prevention and mitigation of the effects of radiation | Sep 14, 2014 | Issued |
Array
(
[id] => 10444479
[patent_doc_number] => 20150329491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/484666
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108827
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/484666 | FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF | Sep 11, 2014 | Abandoned |
Array
(
[id] => 11176435
[patent_doc_number] => 09408407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Compounds, compositions, and methods for reducing or eliminating bitter taste'
[patent_app_type] => utility
[patent_app_number] => 14/480853
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 63126
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/480853 | Compounds, compositions, and methods for reducing or eliminating bitter taste | Sep 8, 2014 | Issued |
Array
(
[id] => 10511081
[patent_doc_number] => 09238655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-19
[patent_title] => 'Heteroaryl pyridone and aza-pyridone compounds'
[patent_app_type] => utility
[patent_app_number] => 14/479529
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 26
[patent_no_of_words] => 207829
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14479529
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/479529 | Heteroaryl pyridone and aza-pyridone compounds | Sep 7, 2014 | Issued |
Array
(
[id] => 11010947
[patent_doc_number] => 20160207900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/917147
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11606
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917147 | Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors | Sep 7, 2014 | Issued |
Array
(
[id] => 9917780
[patent_doc_number] => 20150072985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'USE OF A PPAR-DELTA AGONIST FOR TREATING MUSCLE ATROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/478594
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16408
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/478594 | Use of a PPAR-delta agonist for treating muscle atrophy | Sep 4, 2014 | Issued |
Array
(
[id] => 12254141
[patent_doc_number] => 09926275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Allosteric modulators of the cannabinoid 1 receptor'
[patent_app_type] => utility
[patent_app_number] => 14/911959
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46893
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911959
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911959 | Allosteric modulators of the cannabinoid 1 receptor | Aug 21, 2014 | Issued |
Array
(
[id] => 12226561
[patent_doc_number] => 09913786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Moisturizing composition which may be applied to wet skin in the form of an oil-in-water emulsion; moisturizing care process'
[patent_app_type] => utility
[patent_app_number] => 14/913830
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7813
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913830
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913830 | Moisturizing composition which may be applied to wet skin in the form of an oil-in-water emulsion; moisturizing care process | Aug 20, 2014 | Issued |
Array
(
[id] => 11009619
[patent_doc_number] => 20160206572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'COMPOSITIONS COMPRISING A DENDRIMER-RESVERATROL COMPLEX AND METHODS FOR MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/913272
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21221
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 49
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913272
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913272 | Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same | Aug 20, 2014 | Issued |
Array
(
[id] => 11003773
[patent_doc_number] => 20160200722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/912761
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25472
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912761
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912761 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Aug 17, 2014 | Issued |